Lipocine
LPCN
LPCN
17 hedge funds and large institutions have $1.52M invested in Lipocine in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$30K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$193K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1.5K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$8.18K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$110K |
| 2 |
2
Morgan Stanley
New York
|
$1.82K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$711K |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$75.4K |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$2.13K |
